Abstract Here, cluster analysis showed that a database of 158 anticancer peptides formed 21 clusters based on net positive charge, hydrophobicity and amphiphilicity. In general, these clusters showed similar median toxicities (P = 0.176) against eukaryotic cell lines and no single combination of these properties was found optimal for efficacy. The database contained 14 peptides, which showed selectivity for tumour cell lines only (ACP CT ), 123 peptides with general toxicity to eukaryotic cells (ACP GT ) and 21 inactive peptides (ACP I ). Hydrophobic arc size analysis showed that there was no significant difference across the datasets although peptides with wide hydrophobic arcs ([270°) appeared to be associated with decreased toxicity. Extended hydrophobic moment plot analysis predicted that over 50% of ACP CT and ACP GT peptides would be surface active, which led to the suggestion that amphiphilicity is a key driver of the membrane interactions for these peptides but probably plays a role in their efficacy rather than their selectivity. This analysis also predicted that only 14% of ACP CT peptides compared to 45% of ACP GT peptides were candidates for tilted peptide formation, which led to the suggestion that the absence of this structure may support cancer cell selectivity. However, these analyses predicted that ACP I peptides, which possess no anticancer activity, would also form surface active and tilted a-helices, clearly showing that other factors are involved in determining the efficacy and selectivity of ACPs.
Introduction
Defence peptides are naturally occurring antimicrobial molecules and many have been found to possess toxicity to tumour cells. However, these anticancer peptides (ACPs) differ widely in their efficacy and selectivity for cancer cells. Some ACPs exhibit general toxicity (ACP GT peptides) to eukaryotic cells, killing cancer and non-cancer alike, whilst others show toxicity to cancer cells alone (ACP CT peptides). Moreover, ACP CT peptides can also show selectivity between different types of cancer cells. At present, the factors that determine these differences in efficacy and selectivity are poorly understood, limiting efforts to develop ACPs as therapeutically useful anticancer agents [1, 2] .
Current understanding is that the efficacy and selectivity of ACPs for cancer cells are dependent upon their ability to interact with membranes of the target cells. This ability appears to depend upon the characteristics of the target cell membrane along with a range of physiochemical properties possessed by ACPs with net positive charge, amphiphilicity and hydrophobicity making major contributions [3] . These physiochemical properties are determined by amino acid composition and the secondary structure adopted by the parent molecule with the majority of studies involving peptides that adopt amphiphilic a-helical structure [3] . Many of these peptide a-helices may be classed as surface active and interact with the bilayer such that their orientation is approximately parallel to the membrane surface albeit, sometimes, as an initial step leading to further membrane interactions or cell internalisation. Adopting such orientations allows the polar face of these a-helices to interact with the bilayer head group region whilst their polar face penetrates the hydrophobic membrane core [4] . However, it is becoming increasingly clear that a number of ACPs adopt membrane interactive oblique orientated ahelical structure [5] [6] [7] . Also known as tilted peptides, these are a highly specialised class of amphiphilic a-helix that show some structural similarities to surface active a-helices but differ primarily by possessing an asymmetric distribution of hydrophobicity along the a-helical long axis. This structural feature facilitates membrane penetration by the segment at a shallow angle of between 30°and 60°, thereby inducing a range of membrane-related effects such as the destabilisation of lipid packing [8, 9] .
To date, few large scale databases of ACPs appear to have been presented, limiting the potential for theoretical investigations into factors that influence the anticancer activity of these peptides. However, Owen [10] recently introduced an extensive database of naturally occurring and synthetic a-helical ACPs and in the present study, we have used a variety of theoretical techniques to identify factors that may contribute to differences in the efficacy and selectivity of these peptides.
Methods

Database assembly
A database of anticancer peptides (ACPs) was constructed using data presented by Owen [10] and a-helical structure in these peptides was confirmed using the secondary structure prediction programme: Profile Network from Heidelberg [11] . Toxicity data for these ACPs were also extracted from the database of Owen [10] as the half lethal dose (LD 50 ) against WI38-a normal fibroblast cell line of the lung diploid cells, MCF7-a breast adenocarcinoma tumour cell line, SW480-a colon adenocarcinoma tumour cell line, BMKC-a cloned melanoma cell line, H1299-a lung large cell carcinoma tumour cell line, HeLaS3-a cervical epithelial carcinoma cell line and PC3-a prostate adenocarcinoma tumour cell line. Based on these toxicity data, the dataset of ACPs was further divided into three subsets, which included: 14 peptides which showed selectivity for tumour cell lines only (ACP CT ), 123 peptides with general toxicity to eukaryotic cells (ACP GT ) and 21 inactive peptides (ACP I ).
Extended hydrophobic moment plot analysis
After removal of peptides \11 residues, those remaining in each of the ACP GT , ACP CT and ACP I datasets were analysed using extended hydrophobic moment plot methodology [12] . According to this methodology, the hydrophobicity of successive amino acids in these sequences were treated as vectors and summed in two dimensions, assuming an amino acid side chain periodicity of 100°. The resultant of this summation, the hydrophobic moment hl H i provided a measure of a-helix amphiphilicity [13] . Our analysis used a moving window of 11 residues and for each sequence under investigation the window with the highest hydrophobic moment was identified. For these windows, the mean hydrophobic moment, hl H i, and the corresponding mean hydrophobicity,hHi, which provided a measure of a-helix affinity for the membrane interior, were computed using the normalised consensus hydrophobicity scale of Eisenberg et al. [14] . For each of these datasets, these parameters were then plotted on the extended hydrophobic moment plot diagram of Harris et al. [12] and the location of the data points used to identify sequences that were predicted to be surface active, globular, transmembrane or candidates to form tilted peptides.
Cluster analysis of ACPs
Identification of clusters
To enable comparison of peptides with varying toxicities, the three key parameters known to affect activity, which were net positive charge,hl H i and hHi were determined for each peptide the ACP dataset. Given these parameters are known to affect efficacy the aim was to observe if any key arrangement would be correlated with either high or low toxicity Three-dimensional clustering of the dataset was performed using the statistical unweighted pair group arithmetic averaging (UPGMA), methodology, which was an agglomerative hierarchical technique [15] . The UPGMA tree was reconstructed using Phylip v3.63 (http://evolution.genetics.washington.edu) with the results presented in the form of a dendrogram. As part of the pairwise algorithmic process, Euclidean distances between the data points in multi-dimensional space were used to construct an un-rooted tree together with joining nodes forming a branch. The peptides were clustered according to net positive charge, hHi and hl H i, and were considered as part of a cluster when they were linked to other ACPs by a maximum of two nodes.
Toxicity analysis of clusters
The cell line toxicities of ACPs within clusters were identified and subjected to box plot analysis in order to observe any outliers. This analysis was also used to determine the range of toxicities shown by peptides in each cluster analysed according to net charge, hl H i and hHi, and to enable comparison of clusters mean toxicities. The efficacy of ACPs in each cluster was studied using the cell lines: W138, MCF7, SW480, BMKC, H1299, HeLaS3 and PC3. To statistically compare the cell line toxicities of ACPs between clusters, the Anderson-Darling test was applied to investigate the normal distribution of the data. If P \ 0.005, the data were considered to be non-normally distributed, in which case the Kruskal-Wallis non-parametric test was applied to test the null hypothesis (H 0 ) that there was no significant difference (P [ 0.05) between cell line toxicities for the clusters analysed.
Results
Using UPGMA cluster analysis, a dendrogram of ACPs in the database was constructed, which grouped peptides with similar net positive charge, hHi and hl H i. This analysis produced 1 tree, which was congruent in nodes showing 21 peptide clusters based on similarities in these physiochemical properties. These clusters of ACPs were designated A to U and in order to observe if any given arrangement of net positive charge, hl H i and hHi maximised the efficacy of ACPs, a box plot was used to represent the toxicity values for peptides within each cluster. In the case of the fibroblast cell line, W138 (Fig. 1) , the non-parametric test, Kruskal-Wallis, confirmed that there was a significant difference between medians across the range of clusters (Kruskal-Wallis = 38.261; P = 0.005). Further analysis of Fig. 1 showed that the medians for clusters J and U were higher than those of the other clusters but that there were no significant difference between the medians of the remaining clusters (Kruskal-Wallis = 21.074; P = 0.176).
A box plot was used to represent the toxicity values for peptides within each cluster for each of the different cancer cell lines investigated (Fig. 2) . The Kruskal-Wallis test confirmed that there was a significant difference between the medians across the range of clusters for MCF7 (Kruskal-Wallis = 36.44; P = 0.009), SW480 (Kruskal-Wallis = 31.21; P = 0.027) and BMKC (KruskalWallis = 36.17; P = 0.01). Further analysis of Fig. 2 showed that for MCF7, SW480 and BMKC the median for clusters J, P, Q and U were higher than those of the other clusters. When these clusters are removed from the analysis there is no significant difference between the medians for the remaining clusters (MCF7 Kruskal-Wallis = 15.08; P = 0.446, SW480 Kruskal-Wallis = 16.02; P = 0.312 and BMKC Kruskal-Wallis = 14.46; P = 0.491). There was no significant difference between the medians across the range of clusters for the remaining cell lines H1229 (Kruskal-Wallis = 19.89; P = 0.401), HeLaS3 (KruskalWallis = 26.28; P = 0.123) and PC3 (Kruskal-Wallis = 28.29; P = 0.007). Figure 2 also shows that cluster O contains in active peptides, which were Flak5021, Flak5022 and Flak5026. The remaining inactive peptides were in clusters G, L, J, P, S and U.
The box plot in Fig. 2 also showed that peptides in clusters J and U are less effective across all cell lines. The peptides in these clusters had wide hydrophobic arc sizes *220°implying that a wide hydrophobic arc reduced toxicity. Further statistical analysis of hydrophobic arc sizes for the complete dataset was undertaken and represented as a boxplot in Fig. 3 . These data showed that the hydrophobic arc size of the ACP I , ACP CT and ACP GT peptides ranged from 60°to 260°with ACP GT peptides possessing the widest range (60°-260°) and ACP CT peptides possessing the narrowest range (80°-240°) but the median arc size showed no significant difference (KruskalWallis = 0.01; P = 0.997). The database of ACPs was then interrogated and for each member peptide, its hydrophobic arc size along with its toxicity values (LD 50 ) against the 7 cell lines studied were extracted, collated and plotted on Cartesian planes to produce scatter plots (Fig. 4) . Whilst regression analysis of these data using the method of least squares showed that there was no statistical linear relationship between these two parameters (R 2 = 0.03), Peptides in each of the ACP CT , ACP GT and ACP I datasets were analysed according to extended hydrophobic moment plot methodology [12] . For the ACPs of each of these datasets, plots of hl H i versus hHi were then constructed and according to the location of their data points on the plot diagram (Fig. 5a-c ), peptides were defined as potentially either: surface active, globular or tilted [5] . This analysis predicted that 7 of the ACP I peptides were surface active with 6 potentially able to form tilted peptides. The remaining 2 ACP I peptides were predicted to be globular (Fig. 5a ). This analysis also predicted that 4 ACP CT peptides were surface active with 1 showing the potential to adopt tilted structure. The remaining 2 ACP CT peptides were predicted to be globular (Fig. 5b) . ACP GT peptides represented the biggest single group of ACPs in the database and 57 of these peptides were predicted to be surface active. The remaining ACP GT peptides included 49 that were candidates to form tilted peptides and 4 that showed the potential to be globular (Fig. 5c) . These data are summarised in Table 1 .
Given the apparent importance of surface activity the level of amphiphilicity was further investigated. (9) showed that the hl H i of the ACP I , ACP GT and ACPC T datasets ranged from 0.33 to 1.05. The widest range in the hl H i was observed for the ACP GT peptides (0.33-1.05) and the narrowest range in hl H i was observed for the ACP CT peptides (0.53-0.78). Comparison of the medians across the dataset showed that the median hl H i for ACP GT was 0.74, which was greater than the median of ACP I (median = 0.71) and ACP CT (median = 0.73) peptide datasets. Since there was evidence of non-normality in the hl H i values of peptides in the datasets (Anderson-Darling = 6.315, P \ 0.005), the non-parametric test, Kruskal-Wallis, was used to test the null hypothesis that the medians were the same across the 3 datasets. Here, the null hypothesis was accepted, confirming that there was no significant difference between the hl H i medians of the ACP I , ACP CT and ACP GT peptides (Kruskal-Wallis = 4.391; P = 0.11).
Discussion
At present, the factors that determine differences in the efficacy and selectivity of ACPs are poorly understood, Fig. 3 The hydrophobic arc size of peptides within the ACP I , ACP CT and ACP GT datasets were subjected to box plot analysis. The plot shows the median hydrophobic arc size (dark band) along with the minimum and maximum hydrophobic arc size. The box represents the lower (Q1 = 25%) and upper (Q3 = 75%) quartile range of hydrophobic arc size Fig. 4 Plot of hydrophobic arc size versus the toxicity (LD 50 ) of ACPs in the database for the combined number of cell lines investigated, which were: WI38, MCF7, SW480, BMKC, H1299, HeLaS3 and PC3 Fig. 5 Shown above is extended hydrophobic moment plot analysis of peptides in the ACP I (a), ACP CT (b) and ACP GT (c) datasets. It can be seen that these data points are mainly distributed over the area predicting surface activity and the shaded area, which identifies candidates for oblique orientated a-helix formation Table 1 Summarised above are the classification of peptides [11 residues in the ACP I , ACP CT and ACP GT datasets (Fig. 5a-c inhibiting the potential to develop these peptides as therapeutically useful anticancer agents [1, 2] . However, it is generally accepted that net positive charge, hydrophobicity and amphiphilicity play major roles in the anticancer action of ACPs [1] and here, theoretical analyses are used to study the contribution of these physiochemical properties to the efficacy and selectivity of these peptides. Owen [10] recently introduced an extensive database of a-helical ACPs, which included sequence information and toxicity data for a variety of cancer cell lines. Threedimensional clustering techniques [15] were used to group ACPs of this database with respect to similarity in peptides net positive charge, hHi and hl H i. This produced 21 clusters, A to U. Box plots of these clusters were constructed for each cell line studied and in all cases, toxicities to fibroblast and cancer cell lines were in the low micromolar range (Figs. 1 and 2 ). These box plot analyses showed that the majority of clusters showed similar median cell line toxicities (P = 0.176) and examination of Figs. 1 and 2 showed that no single combination of these 3 properties seemed to increase the overall efficacy of the ACPs analysed. Indeed, the inactive peptides were found across 7 clusters emphasizing that these 3 parameters alone can not be used as predictors of activity.
It is generally accepted that hydrophobicity is a key driver of the ability of ACP peptides to penetrate membranes and hence their anticancer action [3] . In response, the hydrophobic arc sizes of peptides in the ACP database were analyzed and were found to range between 60°and 260°, which is comparable to those observed by Dennison et al. [3] for ACPs (20°-240°). This analysis showed that there appeared to be a general tendency for peptides with arc sizes [270°to be less toxic (MIC values [500 lM) than peptides from other arc sizes but statistical analysis could find no direct correlation between arc size and toxicity. Thus, the fact that ACP I and ACP GT peptides have similar hydrophobic arc sizes to ACP CT peptides clearly suggests that although these physiochemical properties are important to the anticancer action of these latter peptides, other factors must be involved.
In response, the present study used hHi and hl H i along with extended hydrophobic moment plot methodology to consider the impact of the overall molecular architecture on the membrane interactive potential of peptides in the ACP GT , ACP CT and ACP I datasets. Use of this methodology predicted that 56% of these ACP CT peptides and 52% of these ACP GT peptides would be surface active ( Fig. 5b and Fig. 5c ), which is consistent with previous work where it was predicted that surface activity may play an important role in the membrane interactions of ACPs [1] . Moreover, these results clearly suggest that amphiphilicity is a key driver of the membrane interactions of over half the peptides in the dataset and given its importance to both ACP CT and ACP GT peptides, it probably plays a role in the efficacy of the peptides against target cells rather than their selectivity. Extended hydrophobic moment plot analysis further showed that 14% of the ACP CT peptides and 45% of the ACP GT peptides studied were candidates for oblique orientated a-helix formation (Fig. 5c) . Although the ACP CT dataset is small, these results would seem to indicate that in contrast to ACP CT peptides, membrane interaction of ACP GT peptides may more commonly utilise tilted peptide structure. Thus, it may be that use of oblique orientated a-helical structure by ACP GT peptides is associated with their broader spectrum of target specificity as compared to ACP CT peptides. This structure has been associated with relatively non-specific means of cell lysis [1] , which would fit this suggestion.
In the case of amphiphilicity, comparisons across the ACP I , ACP AO and ACP T datasets suggested that there may be an optimal range of values between 0.33 and 1.05, which is in close in agreement with that obtained by Dennison et al. [3] , indicating their high potential as surface active compounds. This architecture is required for the ability of these peptides to interact with the hydrophobic section of a cancer cell membrane, whilst the charged residues remain in contact with the anionic phospholipids on the outer surface, thus ensuring their aggregation onto the surface consequently leading to membrane permeabilization [16, 17] . Statistical analysis showed that there were significant differences between the hl H i values of peptides across the ACP I, ACP CT and ACP GT datasets although those peptides showing cancer cell specificity fell within a narrow range of amphiphilicity (0.53-0.78).
In summary, amphiphilicity appears to be a key driver in the efficacy of most ACP CT peptides and circa half the ACP GT peptides studied here against cell lines. The adoption of oblique orientated a-helical structure by many of the remaining ACP GT peptides may be important to their broad spectrum activity. However, it can be seen from Fig. 3a and Table 1 that peptides of the ACP I dataset, which possess no anticancer activity, would also be predicted to form surface active and tilted a-helices. This is an important result in that it clearly shows that other factors are involved in determining the efficacy and selectivity of ACP CT and ACP GT peptides and strongly supports our previous work where it was suggested that the anticancer activity of ACPs was determined by the interplay of a range of physiochemical characteristics rather than any single over riding factor [3] .
